Probing enzyme stereospecificity. Inhibition of α-chymotrypsin and subtilisin Carlsberg by chiral amine- and aminoalcohol-derivatives

Tetrahedron

Volumn 52, Issue 12, 1996, Pages 4199-4214

  Occhiato, Ernesto ^a   Jones, J Bryan ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN A; ENZYME INHIBITOR; SUBTILISIN;

ARTICLE; CHIRALITY; ENZYME INHIBITION; ENZYME SPECIFICITY; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0029919471     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(96)00078-6     Document Type: Article

References (50)

1. (a) Introduction to Using Biocatalysis Using Enzymes and Microorganisms, Roberts, S.M.; Turner, N.J.; Willetts, A.J.; Turner, M.K., Cambridge University Press, New York, 1995.
2. (b) Enzymes in Synthetic Organic Chemistry; Wong, C. -H.; Whitesides, G. M., Pergamon: N. Y., 1994.
3. c) Biotransformations in Preparative Organic Chemistry; Faber, K., Ed.; Springer-Verlag: Heidelberg, 2nd. ed.,1994.
4. (d) Preparative Biotransformations; Roberts, S.M., Ed.; Wiley: N. Y., 1993.
5. (a) Keller, T. H.; Seufer-Wasserthal, P.; Jones, J. B. Biochem. Biophys. Res. Commun. 1991, 176, 401.
6. (b) Seufer-Wasserthal, P.; Martichonok, V.; Keller, T. H.; Chin, B.; Martin, R.; Jones, J. B. Bioorganic & Medicinal Chemistry 1994, 2, 35.
7. "Catalytic Asymmetric Synthesis", Ojima, I. (ed.), VCH Publishers, New York, 1993, Chaps. 1,2.
8. "The Organic Chemistry of Drug Synthesis", Lednicer, D.; Mitscher, L.A., vols. 1-4, Wiley, New York, 1990
9. (a) Gutman, A. L.; Meyer, E.; Kalerin, E.; Polyak, F.; Sterling, J. Biotechnol. Bioeng. 1992, 40, 760.
10. (b) Pugniere, M.; San Juan, C.; Previero, A. Tetrahedron Lett. 1990, 31, 4883.
11. (c) Gotor, V.; Garcia, M. J.; Rebelleo, F. Tetrahedron Asymmetry 1990, 1, 277.
12. (d) Margolin, A. L.; Delinck, D. L.; Whalon, M. R. J. Am. Chem. Soc. 1990, 112, 2849.
13. (e) Chenevert, R.; Desjardins, M.; Gagnon, R. Chem. Lett. 1990, 33.
14. (f) Ricca, J. M.; Crout, D. H. J. Chem. Soc. Perkin Trans. I 1989, 2126.
15. (g) Kitaguchi, H.; Fitzpatrick, P. A.; Huber, J. E.; Klibanov, A. M. J. Am. Chem. Soc. 1989, 111, 3094.
16. (h) Blevins, R. A.; Tulinsky, A. J. Biol. Chem 1985, 260, 4264.
17. Roper, J. M.; Bauer, D. P. Synthesis 1983, 1041.
18. (a) McPhalen, C. A.; James, M. N. G. Biochemistry 1988, 27, 6582
19. (b) Bode, W.; Papamokos, E.; Musil, D. Eur. J. Biochem. 1987, 166, 673.
20. (a) Frigerio, F.; Coda, A.; Pugliese, L.; Lionetti, C.; Menegatti, E.; Amiconi, G.; Schnebli, H. P.; Ascenzi, P.; Bolognesi, M J. Mol. Biol. 1992, 225, 107.
21. (b) Tsukada, H.; Blow, D. M. M J. Mol. Biol. 1985, 184, 703.
22. (c) Birktoft, J. J.; Blow, D. M. M J. Mol. Biol. 1972, 68, 187.
23. (d) Blevins, R. A.; Tulinsky, A. J. Biol. Chem. 1985, 260, 4264.
24. (e) Tulinsky, A.; Blevins, R. A. J. Biol. Chem. 1987, 262, 7737.
25. (a) Schechter, I.; Berger, A. Biochem. Biophys. Res. Commun. 1967, 27, 157.
26. (b) Berger, A., Schechter, I. Philos. Trans. R. Soc. London, Ser. B 1970, 257, 249.
27. (a) DeZoote, M.C.; Kock-Van Dalen, A.C.; Van Rantwijk, F.; Sheldon, R.A. J. Chem. Soc. Chem. Commun., 1993, 1831.
28. (b) ref. 1 (b) pp. 46-59.
29. (c) ref. 1(c) pp. 298-305.
30. (d) Beck, J.F.; Jones, J.B. Tech. Chem. N.Y., 1976, 10, 187.
31. Jones, J. B.; Sneddon, D. W.; Lewis, A. J. Biochem. Biophys. Acta 1974, 341, 284.
32. Li, Z.; Patil, G. S.; Golubsky, Z. E.; Hori, H.; Tehrani, K.; Foreman, J. E.; Eveleth, D. D.; Bartus, R. T.; Powers, J. C. J. Med. Chem. 1993, 36, 3472-3480.
33. Ocain, T.D.; Rich, D.H. J. Med. Chem. 1992, 35, 451.
34. Lee, A. Y.; Hagihara, M.; Karmachrya, R.; Albers, M. W.; Schreiber, S. L. ; Clardy, J. J. Am. Chem. Soc. 1993, 115, 12619-12620.
35. Thompson, A. S.; Humphrey, G. R.; DeMarco, A. M.; Mathre, D. J.; Grabowski, E. J. J. J. Org. Chem. 1993, 58, 5886-5888.
36. Boyer, J. H. J. Am. Chem. Soc. 1951, 73, 5865-5866.
37. See discussion in footnote 17 in Hultin, P.G; Jones, J.B. Bioorganic Chem., 1992, 20, 30.
38. Wallace, R.A.; Niemann, C. Biochemistry, 1963, 2, 824.
39. (a) 'Techniques of Solubilization of Drugs' Yalkowsky, S. H. Ed.; Marcel Dekker Inc., N. Y., 1981.
40. (b) Schellenberger, V.; Schellenberger, U.; Jakubke, H.-D. Coll. Czech. Chem. Commun., 1988, 53, 2884.
41. (c) Fischer, A.; Schwarz, A.; Wandrey, C.; Bommarius, A.S.; Knaup, G.; Drauz, K. Biomed. Biophys. Acta., 1991, 50, 169.
42. Westermann, B.; Jones, J.B., unpublished work.
43. (a) Fredga, A.; Sjoberg, B.; Sandberg, R. Acta Chem. Scand. 1957, 11, 1609.
44. (b) Okamoto, K.; Minami, E.; Shingu, H. Bull. Chem. Soc. Jpn 1968, 41, 1426.
45. Waley, S. G. Biochem. J. 1982, 205, 631-633.
46. Lee, T.; Jones, J.B. J. Amer. Chem. Soc., 1996, 118, in press.
47. For subtilisin Carlsberg, entry 2SEC, 1.8-Å resolution; for a-chymotrypsin, entry 4CHA, 1.68-Å resolution.
48. (a) Bernstein, F. C.; Koetzle, T. F.; Williams, J. B.; Meyer, E. F., Jr.; Brice, M. D.; Rogers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. J. Mol. Biol. 1977, 112, 535.
49. (b) Abola, E. E.; Bernstein, F. C.; Bryant, S. H.; Koetzle, T. F.; Weng, J. in Crystallographic Databases -Information Content, Software Systems, Scientific Applications; Allen, F. H.; Bergerhoff, G.; Sievers, R., Eds; Data Commision of the International Union of Crystallography: Bonn/ Cambridge/ Chester, 1987, 107.
50. Hagler, A. T.; Osguthorpe, D. J.; Dauber-Osguthorpe, P.; Hempel, J. C. Science 1985, 227, 1309.